Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients
Objective:We evaluated different treatment results reported and showed the effect of treatment at single and multiple clinics for small-cell lung cancer (SCLC). We attempted to show a decreasing impact of chemotherapy (CT) and thoracic radiotherapy (RT) treatment results when implemented at differen...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2016-08-01
|
Series: | Bezmiâlem Science |
Subjects: | |
Online Access: |
http://bezmialemscience.org/archives/archive-detail/article-preview/mportance-of-performing-radiotherapy-and-chemother/20337
|
id |
doaj-4bc00741fd0c4142970365ad6d59676f |
---|---|
record_format |
Article |
spelling |
doaj-4bc00741fd0c4142970365ad6d59676f2020-11-25T00:43:35ZengGalenos Publishing HouseBezmiâlem Science2148-23732148-23732016-08-0142515510.14235/bs.2016.46713049054Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer PatientsHuriye Senay KIZILTAN0Didem TASTEKIN1Ali Hikmet ERIS2Ozgur TASPINAR3Medina ISMAYLOVA4Alpaslan MAYADAGLI5 Department of Radiation Oncology, Bezmialem Vakıf University School of Medicine, İstanbul, Turkey Department of Medical Oncology, Bezmialem Vakıf University School of Medicine, İstanbul, Turkey Department of Radiation Oncology, Bezmialem Vakıf University School of Medicine, İstanbul, Turkey Department Physical Medicine and Rehabilitation, Bezmialem Vakıf University School of Medicine, İstanbul, Turkey Department of Radiation Oncology, Bezmialem Vakıf University School of Medicine, İstanbul, Turkey Department of Radiation Oncology, Bezmialem Vakıf University School of Medicine, İstanbul, Turkey Objective:We evaluated different treatment results reported and showed the effect of treatment at single and multiple clinics for small-cell lung cancer (SCLC). We attempted to show a decreasing impact of chemotherapy (CT) and thoracic radiotherapy (RT) treatment results when implemented at different clinics for SCLC compared to the treatment results at a clinic.Methods:We conducted a retrospective study on 54 non-metastatic SCLC patients who underwent treatments at various clinics. Patients underwent 1–12 courses of CT before they came to the clinic for thoracic RT. RT was performed at 180–400 cGy dose per fraction for a total of 30–52 Gy doses, and patients were followed for 12–60 months.Results:When the study was reviewed, the results showed that the median disease-free survival and survival rates were 8 and 9 months and that the 2-, 5-, and 5-year survival rates were 8%, 6.3%, and 1.8%, respectively. The median progression-free survival rates for 2 and 3 years were 4%, and for 5 years, it was 1.8%. Weight loss for disease-free survival (p=0.01) and superior vena cava syndrome for overall survival (p=0.02) were considered as bad prognostic factors. In this study, acceptable toxicity values were found when the results were compared with those from other studies.Conclusion:We obtained worse results than those from literature data on our SCLC patients who came to our clinic after the progression of their disease. The main causes were identified as insufficient staging and different treatment protocols applied at different clinics. Therefore, we argue that CT and thoracic RT for SCLC must be performed at the same clinic and that the same protocols and staging methods must be used. http://bezmialemscience.org/archives/archive-detail/article-preview/mportance-of-performing-radiotherapy-and-chemother/20337 Small cell lung cancerchemoradiotherapyvena cava syndrome |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Huriye Senay KIZILTAN Didem TASTEKIN Ali Hikmet ERIS Ozgur TASPINAR Medina ISMAYLOVA Alpaslan MAYADAGLI |
spellingShingle |
Huriye Senay KIZILTAN Didem TASTEKIN Ali Hikmet ERIS Ozgur TASPINAR Medina ISMAYLOVA Alpaslan MAYADAGLI Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients Bezmiâlem Science Small cell lung cancer chemoradiotherapy vena cava syndrome |
author_facet |
Huriye Senay KIZILTAN Didem TASTEKIN Ali Hikmet ERIS Ozgur TASPINAR Medina ISMAYLOVA Alpaslan MAYADAGLI |
author_sort |
Huriye Senay KIZILTAN |
title |
Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients |
title_short |
Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients |
title_full |
Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients |
title_fullStr |
Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients |
title_full_unstemmed |
Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients |
title_sort |
importance of performing radiotherapy and chemotherapy in the same clinic and bad prognostic factors for small-cell lung cancer patients |
publisher |
Galenos Publishing House |
series |
Bezmiâlem Science |
issn |
2148-2373 2148-2373 |
publishDate |
2016-08-01 |
description |
Objective:We evaluated different treatment results reported and showed the effect of treatment at single and multiple clinics for small-cell lung cancer (SCLC). We attempted to show a decreasing impact of chemotherapy (CT) and thoracic radiotherapy (RT) treatment results when implemented at different clinics for SCLC compared to the treatment results at a clinic.Methods:We conducted a retrospective study on 54 non-metastatic SCLC patients who underwent treatments at various clinics. Patients underwent 1–12 courses of CT before they came to the clinic for thoracic RT. RT was performed at 180–400 cGy dose per fraction for a total of 30–52 Gy doses, and patients were followed for 12–60 months.Results:When the study was reviewed, the results showed that the median disease-free survival and survival rates were 8 and 9 months and that the 2-, 5-, and 5-year survival rates were 8%, 6.3%, and 1.8%, respectively. The median progression-free survival rates for 2 and 3 years were 4%, and for 5 years, it was 1.8%. Weight loss for disease-free survival (p=0.01) and superior vena cava syndrome for overall survival (p=0.02) were considered as bad prognostic factors. In this study, acceptable toxicity values were found when the results were compared with those from other studies.Conclusion:We obtained worse results than those from literature data on our SCLC patients who came to our clinic after the progression of their disease. The main causes were identified as insufficient staging and different treatment protocols applied at different clinics. Therefore, we argue that CT and thoracic RT for SCLC must be performed at the same clinic and that the same protocols and staging methods must be used. |
topic |
Small cell lung cancer chemoradiotherapy vena cava syndrome |
url |
http://bezmialemscience.org/archives/archive-detail/article-preview/mportance-of-performing-radiotherapy-and-chemother/20337
|
work_keys_str_mv |
AT huriyesenaykiziltan importanceofperformingradiotherapyandchemotherapyinthesameclinicandbadprognosticfactorsforsmallcelllungcancerpatients AT didemtastekin importanceofperformingradiotherapyandchemotherapyinthesameclinicandbadprognosticfactorsforsmallcelllungcancerpatients AT alihikmeteris importanceofperformingradiotherapyandchemotherapyinthesameclinicandbadprognosticfactorsforsmallcelllungcancerpatients AT ozgurtaspinar importanceofperformingradiotherapyandchemotherapyinthesameclinicandbadprognosticfactorsforsmallcelllungcancerpatients AT medinaismaylova importanceofperformingradiotherapyandchemotherapyinthesameclinicandbadprognosticfactorsforsmallcelllungcancerpatients AT alpaslanmayadagli importanceofperformingradiotherapyandchemotherapyinthesameclinicandbadprognosticfactorsforsmallcelllungcancerpatients |
_version_ |
1725277597994057728 |